• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制性卵巢过度刺激及宫腔内人工授精治疗不孕症。

Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility.

作者信息

Dodson W C, Haney A F

机构信息

Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

出版信息

Fertil Steril. 1991 Mar;55(3):457-67. doi: 10.1016/s0015-0282(16)54168-5.

DOI:10.1016/s0015-0282(16)54168-5
PMID:2001748
Abstract

Empirical therapy for subfertility using assisted reproductive technologies recently has gained popularity; however, the cost-effectiveness of these therapies, compared with an untreated control group, has not been established. Similarly, there has been no comparative cost analysis of the utility of controlled ovarian hyperstimulation and IUI in the management of the same condition. Significant PRs in untreated couples with subfertility mandate the design and execution of controlled trials to ascertain the role of controlled ovarian hyperstimulation and IUI in infertility therapy. Various disorders of subfertility have been treated with controlled ovarian hyperstimulation and IUI. The rationale for this therapy is the increase in gamete density at the site of fertilization, as with GIFT and IVF when used for management of the same problems. The live birth rate per initiated cycle and risk of complications are similar to results recently reported for GIFT and IVF. The utility of controlled ovarian hyperstimulation and IUI still remains controversial. When the relatively low direct and indirect costs of controlled ovarian hyperstimulation and IUI are considered, acknowledging the lack of prospective, controlled studies, this procedure appears to be at least as cost-effective as GIFT and IVF.

摘要

近年来,使用辅助生殖技术对不孕症进行经验性治疗越来越普遍;然而,与未治疗的对照组相比,这些治疗方法的成本效益尚未确定。同样,对于控制性卵巢过度刺激和宫腔内人工授精(IUI)在治疗同一病症中的效用,也没有进行过比较成本分析。未治疗的不孕夫妇中显著的妊娠率促使开展对照试验,以确定控制性卵巢过度刺激和IUI在不孕症治疗中的作用。控制性卵巢过度刺激和IUI已被用于治疗各种不孕症。这种治疗的基本原理是,与用于治疗相同问题的配子输卵管内移植(GIFT)和体外受精(IVF)一样,增加受精部位的配子密度。每个启动周期的活产率和并发症风险与最近报道的GIFT和IVF的结果相似。控制性卵巢过度刺激和IUI的效用仍然存在争议。考虑到控制性卵巢过度刺激和IUI相对较低的直接和间接成本,尽管承认缺乏前瞻性对照研究,但该程序似乎至少与GIFT和IVF一样具有成本效益。

相似文献

1
Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility.控制性卵巢过度刺激及宫腔内人工授精治疗不孕症。
Fertil Steril. 1991 Mar;55(3):457-67. doi: 10.1016/s0015-0282(16)54168-5.
2
In vitro fertilisation for unexplained subfertility.不明原因的亚生育力的体外受精。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003357. doi: 10.1002/14651858.CD003357.pub2.
3
In vitro fertilisation for unexplained subfertility.不明原因的亚生育力的体外受精
Cochrane Database Syst Rev. 2002(2):CD003357. doi: 10.1002/14651858.CD003357.
4
A prospective controlled study of in-vitro fertilization, gamete intra-fallopian transfer and intrauterine insemination combined with superovulation.体外受精、配子输卵管内移植及宫腔内人工授精联合超排卵的前瞻性对照研究。
Hum Reprod. 1992 Apr;7(4):490-4. doi: 10.1093/oxfordjournals.humrep.a137677.
5
Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?试管婴儿服务有两种不同方式——比控制性卵巢过度刺激下的宫腔内人工授精更具成本效益吗?
Hum Reprod. 2015 Oct;30(10):2331-9. doi: 10.1093/humrep/dev193. Epub 2015 Aug 12.
6
Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial.促性腺激素刺激宫腔内人工授精或体外受精治疗不明原因不孕不育症:一项随机对照试验。
Fertil Steril. 2017 Jun;107(6):1329-1335.e2. doi: 10.1016/j.fertnstert.2017.03.028. Epub 2017 May 10.
7
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis.特发性不孕和男性不育的宫内人工授精或体外受精:一项随机试验和成本效益分析。
Lancet. 2000 Jan 1;355(9197):13-8. doi: 10.1016/S0140-6736(99)04002-7.
8
In vitro fertilization, gamete intrafallopian transfer, and superovulation with intrauterine insemination: efficacy and potential health hazards on babies delivered.体外受精、配子输卵管内移植以及超排卵联合宫腔内人工授精:对分娩婴儿的疗效及潜在健康危害。
Am J Obstet Gynecol. 1996 Apr;174(4):1208-17. doi: 10.1016/s0002-9378(96)70663-4.
9
Gamete intra-fallopian transfer or intrauterine insemination after controlled ovarian hyperstimulation for treatment of infertility due to endometriosis.在控制性卵巢过度刺激后进行配子输卵管内移植或宫腔内人工授精,以治疗子宫内膜异位症所致不孕症。
Gynecol Endocrinol. 2004 Sep;19(3):152-9. doi: 10.1080/09513590400004710.
10
Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men.男性不育症采用定时性交与宫内人工授精(无论是否进行卵巢超刺激)的比较
Cochrane Database Syst Rev. 2000(2):CD000360. doi: 10.1002/14651858.CD000360.

引用本文的文献

1
Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks.干细胞与不孕症:临床应用及法律框架综述
J Pers Med. 2024 Jan 24;14(2):135. doi: 10.3390/jpm14020135.
2
Phytochemicals: Alternative for Infertility Treatment and Associated Conditions.植物化学物质:治疗不孕不育及相关病症的替代方法。
Oxid Med Cell Longev. 2023 May 11;2023:1327562. doi: 10.1155/2023/1327562. eCollection 2023.
3
Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.
高龄妇女的排卵诱导和宫腔内人工授精:文献系统评价。
J Assist Reprod Genet. 2022 Jul;39(7):1445-1491. doi: 10.1007/s10815-022-02551-8. Epub 2022 Jun 22.
4
Application of Stem Cell Therapy for Infertility.干细胞治疗在不孕不育中的应用。
Cells. 2021 Jun 28;10(7):1613. doi: 10.3390/cells10071613.
5
Increased Estradiol Levels Effect on Leptin Expression in Midluteal Endometrial Tissue of Macaca Nemestrina (Southern Pig-Tailed Macaques).雌二醇水平升高对豚尾猕猴(南豚尾猴)黄体中期子宫内膜组织中瘦素表达的影响。
J Family Reprod Health. 2020 Dec;14(4):229-233. doi: 10.18502/jfrh.v14i4.5206.
6
Comparing the Effectiveness of Doing Intra-uterine Insemination 36 and 42 Hours After Human Chorionic Gonadotropin (HCG) Injection on Pregnancy Rate: A Randomized Clinical Trial.比较人绒毛膜促性腺激素(HCG)注射后36小时和42小时进行宫内人工授精对妊娠率的有效性:一项随机临床试验。
J Family Reprod Health. 2020 Sep;14(3):173-179. doi: 10.18502/jfrh.v14i3.4670.
7
Comparison of two sperm processing techniques for low complexity assisted fertilization: sperm washing followed by swim-up and discontinuous density gradient centrifugation.两种用于低复杂性辅助受精的精子处理技术的比较:精子洗涤后上浮法与不连续密度梯度离心法。
JBRA Assist Reprod. 2016 Dec 1;20(4):206-211. doi: 10.5935/1518-0557.20160040.
8
Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study.不明原因不孕症患者宫腔内人工授精后的妊娠预测因素:一项前瞻性研究。
Int J Reprod Med. 2016;2016:5817823. doi: 10.1155/2016/5817823. Epub 2016 Sep 21.
9
Which is the best intrauterine insemination timing choice following exogenous hCG administration during ovulation induction by using clomiphene citrate treatment? A retrospective study.在使用枸橼酸氯米芬治疗诱导排卵过程中外源性人绒毛膜促性腺激素给药后,最佳的宫腔内人工授精时机选择是什么?一项回顾性研究。
Springerplus. 2016 Aug 9;5(1):1307. doi: 10.1186/s40064-016-2992-9. eCollection 2016.
10
Gonadotropin Alone is a Better Drug for Ovarian Stimulation than in Combination with Clomiphene in Intrauterine Insemination.在子宫内授精中,单独使用促性腺激素比与克罗米芬联合使用更适合用于卵巢刺激。
J Obstet Gynaecol India. 2016 Oct;66(5):333-8. doi: 10.1007/s13224-015-0686-9. Epub 2015 Mar 13.